Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.
Ongoing Scripps research into polygenic risk for coronary artery disease now offers remote genetic counseling as well as an Android app.
Fresh off its first major fundraise, the startup DTC biobanking company is preparing to launch a new service under the GoodCell Diagnostics brand name.
The fledgling company, started as a promise to the founder's dying sister, is trying to succeed in a consumer niche where so many others have failed.
The companies had agreed in early 2018 to collaborate on the development of technologies to support precision oncology initiatives, but Roche said "priorities" have changed.
The clinical decision support content developer is integrating genetic testing information into its knowledgebase to assist physicians at the point of care.
A study group eager to learn about genetic testing online was not won over by videos produced by academics without communication expertise.
Recent studies question the clinical utility of tumor mutational burden as a biomarker for immuno-oncology response, and the FDA clearance includes no therapeutic indications.
Accredited by the same group behind MP3 audio, the new genomics standard promises more efficient data handling, but fans of GA4GH file formats are pushing back.
Microsoft is applying its Project Hanover AI to Jackson Laboratory's Clinical Knowledgebase to help tumor boards find appropriate therapies based on tumor mutations.
The deal with AstraZeneca serves to validate the company's technology, while two new distributors have raised the software vendor's international profile.
The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.
The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.
News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.
In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.